Cytosorbents Corporation (FRA:HQE1)

Cytosorbents Revenue

Cytosorbents had revenue of $9.49M USD in the quarter ending September 30, 2025, with 10.12% growth. In the year 2024, Cytosorbents had annual revenue of $35.59M with 14.51% growth.

• Revenue: $35.59M
• Revenue Growth: +14.51%
• P/S Ratio: 1.29
• Revenue / Employee: $238.89K
• Employees: 149
• Market Cap: 40.52M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	35.59M	4.51M	14.51%
Dec 31, 2023	31.08M	-3.60M	-10.39%
Dec 31, 2022	34.69M	-8.48M	-19.64%
Dec 31, 2021	43.17M	2.16M	5.27%
Dec 31, 2020	41.00M	16.06M	64.35%
Dec 31, 2019	24.95M	2.45M	10.87%
Dec 31, 2018	22.50M	7.35M	48.53%
Dec 31, 2017	15.15M	5.62M	59.02%
Dec 31, 2016	9.53M	4.74M	98.84%
Dec 31, 2015	4.79M	668.79K	16.22%
Dec 31, 2014	4.12M	1.70M	70.18%
Dec 31, 2013	2.42M	1.08M	80.40%
Dec 31, 2012	1.34M	1.31M	3,622.31%
Dec 31, 2011	36.08K	-	-
Dec 31, 2010	-	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-